Location of Repository

Aztreonam therapy in experimental meningitis due to Haemophilus influenzae type b and Escherichia coli K1.

By G H McCracken, Y Sakata and K D Olsen

Abstract

The penetration of aztreonam into cerebrospinal fluid was 7 to 15% and 9 to 25%, respectively, in experimental Haemophilus influenzae type b and Escherichia coli K1 meningitis. Aztreonam was effective in reducing the number of organisms in cerebrospinal fluid after single-dose and continuous infusion administration, and the median bactericidal titers in cerebrospinal fluid were 1:32 against both meningeal pathogens

Topics: Research Article
Year: 1985
OAI identifier: oai:pubmedcentral.nih.gov:180117
Provided by: PubMed Central
Sorry, our data provider has not provided any external links therefor we are unable to provide a PDF.

Suggested articles


To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.